Health SCORE analysis of semaglutide 2.4 mg demonstrated risk reduction in cardiovascular events in a real-world setting March 31, 2025
Health Akeso’s 2024 Results: Strengthening Global Competitiveness and Transforming the Treatment Landscape with Bispecific Antibodies March 31, 2025
Health Ozempic® (semaglutide) injection 1 mg showed improved functional outcomes and health-related quality of life in Phase 3 STRIDE trial in adults with type 2 diabetes and peripheral artery disease (PAD) presented at ACC 2025 March 30, 2025
Health WELL Health Announces Delay in Filing of Annual Audited Financial Statements Due to Matter Related to US Subsidiary Circle Medical March 29, 2025
Health Zylox-Tonbridge Announces 2024 Annual Results: Achieves Full-Year Profit for the First Time with Net Profit Exceeding USD 14 Million March 29, 2025
Health Fenplast proudly celebrates its participation in the 20th anniversary of the Leucan Ski Challenge March 29, 2025
Health FDA Approves Novel Treatment for Hemophilia A or B, with or without Factor Inhibitors March 29, 2025